Role of lymphadenectomy in disease-free and overall survival on low risk endometrium cancer patients
Özet
Objectives: Evaluation of the effect of lymphadenectomy in disease-free and overall survival on the low risk corpus cancer. Material and methods: Between 1994 and 2012, a total of 257 patients with endometrioid type, grade 1 or 2, myometrial invasion < 1/2, no intraoperative evidence of macroscopic extrauterine spread was treated surgically. Pelvic lymphadenectomy was performed in 184 cases, and not performed in 73 cases. Results: There was no difference between two groups about tumor sizes. Also lymphovascular space invasion and histologic grade of two groups were similar. Omission of LA did not worsen DFS and OS in early stage low risk corpus cancer. Conclusions: Patients who have low risk corpus cancer, can be treated optimally with hysterectomy only. © 2018 Via Medica.
Anahtar Kelimeler
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Turkler, Can | |
| dc.contributor.author | Kulhan, Mehmet | |
| dc.contributor.author | Kulhan, Nur Gozde | |
| dc.contributor.author | Ata, Nahit | |
| dc.contributor.author | Sanci, Muzaffer | |
| dc.contributor.author | Ozeren, Mehmet | |
| dc.date.accessioned | 2026-10-18T20:29:15.263160977Z | |
| dc.date.available | 2026-10-18T20:29:15.263160977Z | |
| dc.date.issued | 2018 | |
| dc.description.abstract | Objectives: Evaluation of the effect of lymphadenectomy in disease-free and overall survival on the low risk corpus cancer. Material and methods: Between 1994 and 2012, a total of 257 patients with endometrioid type, grade 1 or 2, myometrial invasion < 1/2, no intraoperative evidence of macroscopic extrauterine spread was treated surgically. Pelvic lymphadenectomy was performed in 184 cases, and not performed in 73 cases. Results: There was no difference between two groups about tumor sizes. Also lymphovascular space invasion and histologic grade of two groups were similar. Omission of LA did not worsen DFS and OS in early stage low risk corpus cancer. Conclusions: Patients who have low risk corpus cancer, can be treated optimally with hysterectomy only. © 2018 Via Medica. | |
| dc.identifier.doi | 10.5603/gp.a2018.0053 | |
| dc.identifier.eissn | 2543-6767 | |
| dc.identifier.endpage | 315 | |
| dc.identifier.issn | 0017-0011 | |
| dc.identifier.issue | 6 | |
| dc.identifier.pmid | 30010179 | |
| dc.identifier.scopus | 2-s2.0-85049252809 | |
| dc.identifier.startpage | 311 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/ebyu/14443 | |
| dc.identifier.volume | 89 | |
| dc.identifier.wos | WOS:000438933600004 | |
| dc.language.iso | en | |
| dc.publisher | Via Medica | |
| dc.relation.ispartof | Ginekologia Polska | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | Endometrial cancer | |
| dc.subject | Low risk | |
| dc.subject | Lymphadenectomy | |
| dc.subject | Adult | |
| dc.subject | Aged | |
| dc.subject | Carcinoma, Endometrioid | |
| dc.subject | Endometrial Neoplasms | |
| dc.subject | Female | |
| dc.subject | Humans | |
| dc.subject | Hysterectomy | |
| dc.subject | Lymph Node Excision | |
| dc.subject | Male | |
| dc.subject | Middle Aged | |
| dc.subject | Neoplasm Staging | |
| dc.subject | Poland | |
| dc.subject | Prognosis | |
| dc.subject | Survival Analysis | |
| dc.subject | cancer staging | |
| dc.subject | comparative study | |
| dc.subject | endometrioid carcinoma | |
| dc.subject | endometrium tumor | |
| dc.subject | human | |
| dc.subject | lymph node dissection | |
| dc.subject | pathology | |
| dc.subject | statistics and numerical data | |
| dc.title | Role of lymphadenectomy in disease-free and overall survival on low risk endometrium cancer patients | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.scopus | 7 | |
| rdl.citation.wos | 5 | |
| rdl.department | Department of Obstetrics and Gynecology, Erzincan University, Turkey | |
| rdl.department | Izmir Tepecik Teaching and Research Hospital, Department of Obstetrics and Gynecology, yenişehir, 35150 izmir, Turkey. dr_canturkler@yahoo.com. | |
| rdl.oa.status | gold | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |
